About Brainomix
Brainomix is a company based in Oxford (United Kingdom) founded in 2010 by Andrew Charles Barker.. Brainomix has raised $52.78 million across 7 funding rounds from investors including Tencent, Boehringer Ingelheim and IP Group. The company has 29 employees as of December 31, 2019. Brainomix offers products and services including Brainomix 360 Stroke, e-Lung, and Cancer AI Solution. Brainomix operates in a competitive market with competitors including AIdoc, HeartFlow, IXICO, Median and AI Medical Service, among others.
- Headquarter Oxford, United Kingdom
- Employees 29 as on 31 Dec, 2019
- Founders Andrew Charles Barker
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Brainomix Limited
- Date of Incorporation 02 Nov, 2010
- Jurisdiction OXFORD, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$52.78 M (USD)
in 7 rounds
-
Latest Funding Round
$18 M (USD), Series C
Mar 20, 2025
-
Investors
Tencent
& 7 more
-
Employee Count
29
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brainomix
Brainomix offers a comprehensive portfolio of products and services, including Brainomix 360 Stroke, e-Lung, and Cancer AI Solution. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated AI solution for stroke assessment and decision support
AI-powered tool for evaluating interstitial lung diseases
Automated system for assessing solid tumors in clinical trials
Unlock access to complete
Unlock access to complete
Funding Insights of Brainomix
Brainomix has successfully raised a total of $52.78M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $18 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $18.0M
-
First Round
First Round
(30 Sep 2014)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series C - Brainomix | Valuation | Parkwalk , Boehringer Ingelheim | |
| Dec, 2021 | Amount | Series B - Brainomix | Valuation | Boehringer Ingelheim Venture Fund , Parkwalk | |
| Apr, 2018 | Amount | Series A - Brainomix | Valuation | Parkwalk , Boehringer Ingelheim Venture Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Brainomix
Brainomix has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Boehringer Ingelheim and IP Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture capital and advisory services are offered across multiple sectors.
|
Founded Year | Domain | Location | |
|
Healthcare investments are targeted by Boehringer Ingelheim Venture Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Brainomix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Brainomix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Brainomix Comparisons
Competitors of Brainomix
Brainomix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, HeartFlow, IXICO, Median and AI Medical Service, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| domain | founded_year | HQ Location |
Cardiovascular diagnostics are provided using CT scans and analytics.
|
|
| domain | founded_year | HQ Location |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| domain | founded_year | HQ Location |
Medical imaging software and services are provided for clinical trials.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| domain | founded_year | HQ Location |
Robotic surgery platform for bone procedures is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Brainomix
Frequently Asked Questions about Brainomix
When was Brainomix founded?
Brainomix was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Where is Brainomix located?
Brainomix is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Brainomix a funded company?
Brainomix is a funded company, having raised a total of $52.78M across 7 funding rounds to date. The company's 1st funding round was a Series A of $9.8M, raised on Sep 30, 2014.
How many employees does Brainomix have?
As of Dec 31, 2019, the latest employee count at Brainomix is 29.
What does Brainomix do?
Brainomix was founded in 2010 and is based in Oxford, United Kingdom. AI-powered imaging biomarkers are developed for precision medicine in the medical imaging sector. Stroke imaging solutions, including e-ASPECTS, e-CTA, and e-CTP, are offered alongside e-ILD for Interstitial Lung Disease assessment. Medical imaging software is being created to interpret brain CT scans automatically, utilizing biomarkers for stroke diagnosis. Operations focus on automated analysis for clinical use.
Who are the top competitors of Brainomix?
Brainomix's top competitors include AIdoc, eCential Robotics and IXICO.
What products or services does Brainomix offer?
Brainomix offers Brainomix 360 Stroke, e-Lung, and Cancer AI Solution.
Who are Brainomix's investors?
Brainomix has 8 investors. Key investors include Tencent, Boehringer Ingelheim, IP Group, European Union, and Oxford University Innovation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.